FindTrial
Sign In

Efficacy Of Apamarga Kshar Injection in Vrangrathi With Special Reference To Keloids

The Efficacy Of Apamarga Kshar Injection in Vrangrathi With Special Reference To Keloids - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092197
Enrollment
40
Registered
2025-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

APMS Ayurved Mahavidyalaya Sion
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Keloids scaring patient Keloids size 1-10cm

Exclusion criteria

Exclusion criteria: Open wound Infected wound, Immuno compromised patient, Diabetic patients, Pregnancy, Lactation, Vrangrathi over Marmastana

Design outcomes

Primary

MeasureTime frame
Does Intra lesional administration of Apamarga Kshar Injection reduce size and symptoms of Vrangrathi (Keloids)Timepoint: Once a week for 6 week—

Secondary

MeasureTime frame
Symptomatic relief in keloids condition like itching tendernessTimepoint: 6 week—

Countries

India

Contacts

Public ContactDr Amruta Radheshyamji Somani

A.P.M.s Ayurved Mahavidyalaya Sion Mumbai

sheela.kohad@hotmail.com9920752538

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026